Bloodstream Infection Testing Market: Top Geographies and Market Highlights

Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., and F. Hoffmann La Roche Ltd are among the key vendors discussed in the research report

The bloodstream infection testing market is set to post an incremental growth of $ 3.56 bn, accelerating at a CAGR of about 8% during the forecast period. Our market investigates the key markets and the factors that are likely to boost growth along with challenges that need to be surpassed to promote success in the market. The report also provides an analysis of key segments and offers competitive benchmarking of the key market players and their product portfolios.

For market insights and a better understanding of the quality of our research:

Request for our FREE Sample Report

Bloodstream Infection Testing Market: North America to lead market growth during the forecast period

• North America emerged as the leading geographical segment in recent years and is expected to contribute 42% of the market growth during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the bloodstream infection testing market size.
• Increasing hospital visits will be a significant factor in driving the growth of the bloodstream infection testing market. This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. This analysis will thus enable clients to assess their play in the market and plan for growth opportunities.
• Market is segmented by Technology (Conventional testing and Non-conventional testing) and Geography (North America, Europe, Asia, and ROW).

Bloodstream Infection Testing Market: Competitive Landscape

Some of the leading vendors in this market are Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.. The market is fragmented and the growth of the players in this market is dependent on several factors such as prevalent market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. For more insights on this market: Download a Free Sample Report

Browse through some of other related market research reports for more insights:

• Artificial Blood Substitutes Market: The Global artificial blood substitutes market is expected to grow by $ 7.38 billion, accelerating at a CAGR of almost 23% during the forecast period.
• Immunohematology Market: Global immunohematology market will post an incremental growth of $ 907.43 million and progressing at a CAGR of almost 7.75% during the forecast period.
• Bilirubin Blood Test Market: The Global Bilirubin Blood Test Market is projected to grow by $ 619.10 million, accelerating at a CAGR of over 8% till 2025.
• Sickle Cell Disease Treatment Market: Global sickle cell disease treatment market is likely to post an incremental growth of $ 2.33 billion, accelerating at a CAGR of 11.36% during the forecast period.

The report provides insights into the following FAQs:

1. What is the market CAGR?
   The market will accelerate at a CAGR of about 8%.
    
2. What is the incremental growth of the market?
   The market is expected to grow by $ 3.56 bn through 2021-2025.
    
3. What is a key factor driving this market?
   Increasing hospital visits will drive market growth over the forecast period.
    
4. What are the key regions covered in this market research report?
   North America, Europe, Asia, and ROW are the key regions featured in this research report.
    
5. Which is the leading geographic region for this market:
   42% growth will originate from North America
    
6. Who are the leading market vendors?
   The leading vendors in this market are Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
    
7. What are the market segments covered in this report?
   The market is segmented by Technology (Conventional testing and Non-conventional testing) and Geography (North America, Europe, Asia, and ROW).

Market Segmentation by Technology

• • Bloodstream Infection Testing Market Split by Technology
    • Conventional testing
    • Non-conventional testing
  • Bloodstream Infection Testing Market Split by Geography
    • North America
    • Europe
    • Asia
    • ROW

Customer landscape

• Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• APAC - Market size and forecast 2020-2025
• MEA - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• North America - Market size and forecast 2020-2025
• South America - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Competitive scenario
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Abbott Laboratories
• Accelerate Diagnostics Inc.
• Becton, Dickinson and Co.
• bioMerieux SA
• Bruker Corp.
• Danaher Corp.
• F. Hoffmann La Roche Ltd.
• Grifols SA
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

Bloodstream Infection Testing Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025

Technavio has been monitoring the bloodstream infection testing market and it is expected to grow by $ 3.56 bn, accelerating at a CAGR of almost 8.01% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking

Bloodstream Infection Testing Market: Receive Free Sample Report

Bloodstream Infection Testing Market: Key Trends to impact market growth

Growth by the conventional testing segment will be significant during the forecast period. The low cost, and therefore the high availability of conventional testing standards are reasons for the larger share of the segment.  North America has been exhibiting a significant growth rate for bloodstream infection testing market vendors. Factors such as high awareness of blood safety and transfusion-transmitted infections are accelerating the bloodstream infection testing market growth in the region. However, market share growth in North America will be slower than that in Asia during the forecast period. This research report provides a detailed impact analysis of all the trends that are likely to influence the growth of the market in focus.

Bloodstream Infection Testing Market: Top Drivers to Boost Demand

Increase in hospital visits is one of the primary factors driving the growth of the bloodstream infection testing market. The prevalence of chronic diseases is increasing globally, which in turn, is raising the number of patient visits to hospitals. Hospitals are a prominent source of infection, resulting in a rise in morbidity and mortality in hospitalized patients. Intensive care units are often the epicenter of these infections, mainly because they are vulnerable to infections through multiple invasive, therapeutic, and diagnostic procedures. The report provides a detailed study of all the factors that are likely to boost the market. This analysis will enable clients to leverage growth opportunities to their advantage and set their business ont he path to future growth.

Vendor Analysis: Abbott Laboratories, Accelerate Diagnostics Inc. and Becton, Dickinson and Co. are key growth contributors

The market is fragmented. The research report provides insights into the top market player and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants.

For more insights on this market: Download a Free Sample Report

Bloodstream Infection Testing Market: Key Highlights of the Report for 2021-2025

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive bloodstream infection testing market growth during the next five years
• Precise estimation of the bloodstream infection testing market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the bloodstream infection testing market industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of bloodstream infection testing market vendors